KYLE LONG: Open Payments
NPI 1609814391 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$441 in 22 payments from 4 companies in 2025. Trend: 2023 $634 · 2024 $430 · 2025 $441
Food & beverage: $441
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 11 | $235 |
| Alkermes, Inc. | 5 | $100 |
| Teva Pharmaceuticals USA, Inc. | 5 | $81 |
| ABBVIE INC. | 1 | $25 |
Products named: INGREZZA, ARISTADA, AUSTEDO XR, UZEDY, VRAYLAR.
Industry payments across NC — which companies pay providers there.
